| Q48311711 | Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia |
| Q34201567 | Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder |
| Q48071023 | Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients |
| Q38628562 | An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias |
| Q44563750 | An optimistic view for quantifying mRNA in post-mortem human brain |
| Q36121377 | Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program |
| Q35106821 | Biochemical and molecular studies using human autopsy brain tissue |
| Q48453334 | Brain Cytochrome Oxidase in Alzheimer's Disease |
| Q35655969 | Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials |
| Q99585321 | Can post-mortem MRI be used as a proxy for in vivo? A case study |
| Q59449727 | Chapter 7 Brain banking and the human hypothalamus — factors to match for, pitfalls and potentials |
| Q37622623 | Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation |
| Q33186270 | Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease |
| Q42440569 | Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. |
| Q37585523 | Dysregulation of the fibroblast growth factor system in major depression |
| Q34994246 | Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain |
| Q47397177 | Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra |
| Q35607880 | Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease |
| Q44327712 | How important are brain banks for alcohol research? |
| Q59449391 | IL-1β immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis |
| Q53322786 | Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type. |
| Q48374083 | Inositol levels are decreased in postmortem brain of schizophrenic patients |
| Q37651013 | Isolation of primary microglia from the human post-mortem brain: effects of ante- and post-mortem variables |
| Q59808733 | Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease |
| Q36083471 | Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease |
| Q46676906 | Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis |
| Q45155062 | Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease |
| Q37329070 | Methodological considerations for gene expression profiling of human brain. |
| Q34994209 | Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders |
| Q48682959 | Monoaminergic dysfunction in Sjögren-Larsson syndrome |
| Q48583796 | Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium |
| Q42450310 | Neuropathological alterations in alcoholic brains. Studies arising from the New South Wales Tissue Resource Centre |
| Q69727957 | Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level |
| Q30422050 | Postmortem brain: an underutilized substrate for studying severe mental illness |
| Q52172492 | Postnatal ontogeny of GTP binding protein in the human frontal cortex. |
| Q40487622 | Pre‐and Postmortem Influences on Brain RNA |
| Q37053850 | Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology |
| Q30485119 | Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies |
| Q48826421 | Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains |
| Q48892320 | Quantification of presenilin-1 mRNA in Alzheimer's disease brains |
| Q44618044 | Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance |
| Q54372687 | RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays. |
| Q44438171 | Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease |
| Q37239959 | Regulation of a novel alphaN-catenin splice variant in schizophrenic smokers |
| Q33300170 | Sample matching by inferred agonal stress in gene expression analyses of the brain |
| Q34176902 | Selection of reference gene expression in a schizophrenia brain cohort |
| Q53393272 | Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology. |
| Q36867149 | The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research |
| Q36805238 | The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007 |
| Q48656601 | Three-dimensional mapping of norepinephrine and serotonin in human thalamus |
| Q36617348 | Tissue preparation and banking |
| Q47442924 | Towards an Understanding of Energy Impairment in Huntington's Disease Brain |
| Q64777619 | Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson's disease |
| Q87927295 | What can we learn about brain donors? Use of clinical information in human postmortem brain research |
| Q35940273 | pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. |